Skip to main content

Articles

Page 1 of 20

  1. People in the United States who use opioids frequently use emergency department (ED) services. Some hospitals have begun placing peer recovery support specialists (PRSS) in EDs to support and advocate for pati...

    Authors: Martha Tillson, Huiping Xu, Alan McGuire, Spencer Medcalf, Francesca L. Beaudoin and Dennis P. Watson
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:21
  2. A new transitional housing program was established in Sudbury, Ontario, Canada, in response to the escalating prevalence of substance use and homelessness, and the specific challenges faced in Northern Ontario...

    Authors: Kristen A. Morin, Natalie Aubin, Daniel Molke, David C. Marsh, Neil St Jean, Jada Carter and Tara Leary
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:20
  3. Methamphetamine use is a pressing public health concern among people who inject drugs (PWID) worldwide. This study aimed to estimate the prevalence of methamphetamine use and its correlates in a nationwide sur...

    Authors: Yasaman Mansoori, Soheil Mehmandoost, Mehrdad Khezri, Ali Mirzazadeh, Ali Akbar Haghdoost, Fatemeh Tavakoli, Naser Nasiri, Mohammad Sharifi, Hamidreza Rashidi, Abedin Iranpour, Mostafa Shokoohi, Nima Ghalekhani, Marjan Pedarzadeh, Surur Fuladi, Mohammad Karamouzian and Hamid Sharifi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:19
  4. Opioid use disorder (OUD) is highly prevalent among jail and prison populations in the United States, including in Wisconsin. Medications for opioid use disorder (MOUD), including long-acting injectable naltre...

    Authors: Jason S. Chladek and Michelle A. Chui
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:17
  5. Public authorities use a variety of control policies, with varying degrees of severity, to reduce the prevalence of health-damaging habits. Since these policies can only succeed if people understand and approv...

    Authors: Daniel del Rio Forero, Claudia Pineda Marín, María Teresa Muñoz Sastre, Lonzozou Kpanake and Etienne Mullet
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:16
  6. Underutilization of medications for opioid use disorder (MOUD) remains a persistent obstacle to addressing the opioid epidemic. This study explores MOUD agency experiences with patient census growth as well as...

    Authors: Hannah K. Knudsen, Shaquita Andrews-Higgins, Sandra Back-Haddix, Michelle R. Lofwall, Laura Fanucchi and Sharon L. Walsh
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:15
  7. Rumination is an essential trans-diagnostic process associated with substance use disorders (SUDs) in psychopathology. In China, methamphetamine and heroin have become major illegal drugs, but the role of rumi...

    Authors: Yinxue Mao, Deyang Li, Dongmei Wang, Yang Tian, Jiajing Chen, Lianglun Jia, Xiaotao Wang and Xiang-Yang‍ Zhang‍‍
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:14
  8. Binge drinking constitutes a significant public health concern. Defined as the consumption of five or more alcoholic beverages on a single occasion, binge drinking leads to acute cognitive and motor impairment...

    Authors: Sa’ed H. Zyoud
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:13
  9. Cognitive deficits are prevalent among substance use disorder (SUD) patients and affect treatment retention and outcome. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) is a well...

    Authors: Kristoffer Høiland, Rune Raudeberg and Jens Egeland
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:12
  10. The Drug User Liberation Front led an evaluation of a non-medicalized model of safer supply known as a “Compassion Club.” This club sourced, rigorously tested, packaged, and accurately labeled certain illicit ...

    Authors: Jeremy Kalicum, Eris Nyx, Mary Clare Kennedy and Thomas Kerr
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:11
  11. Heavy consumption of alcohol increases the risk of developing active tuberculosis (TB), contributes to delayed diagnosis and affects adherence to treatment. Within a large urban case-finding project, we aimed ...

    Authors: Josephine Bayigga, Ilona Kakai, Eva Agnes Laker Odongpiny, Ahmed Ddungu, Lynn Semakula, Martha Nansereko, Christine Sekaggya Wiltshire, Turyahabwe Stavia and Stella Zawedde-Muyanja
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:10
  12. Canada continues to experience an epidemic of toxic drug-related overdose deaths. Public health messaging emphasizes the dangers of using drugs alone as it restricts timely overdose response or renders it impo...

    Authors: Kat Gallant, Kanna Hayashi, Eric C. Sayre, JinCheol Choi, Manal Mansoor and Thomas Kerr
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:9
  13. The opioid epidemic contributes to increasing morbidity and mortality due to drug overdoses in the US, but barriers to traditional opioid use disorder (OUD) treatment prevent a vast majority of patients from a...

    Authors: Laura B. Monico, Megan Eastlick, Darcy Michero, Peyton Pielsticker and Suzette Glasner
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:8
  14. Early identification of potential alcohol-problems is central for timely intervention and treatment referral. The Alcohol Use Disorders Identification Test (AUDIT) and AUDIT-Consumption (AUDIT-C) serve as glob...

    Authors: Peter Næsborg Schøler, Max Benjamin Andersen, Kjeld Andersen, Ulrik Becker, Maja Thiele and Anette Søgaard Nielsen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:7
  15. Substance use disorders are prevalent among youth in sub-Saharan Africa (SSA), yet treatment resources are scarce. Peer provider delivered brief interventions (BIs) represent an affordable and potentially scal...

    Authors: Florence Jaguga, Matthew C. Aalsma, Leslie A. Enane, Matthew Turissini, Edith Kamaru Kwobah, Edith Apondi, Julius Barasa, Gilliane Kosgei, Yvonne Olando and Mary A. Ott
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:6
  16. Little is known about mortality from four disorder combinations: fully attributable to alcohol or tobacco, partly attributable to both alcohol and tobacco, to tobacco only, to alcohol only.

    Authors: Ulrich John, Hans-Jürgen Rumpf, Monika Hanke and Christian Meyer
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:5
  17. Alternative payment models (APMs) are methods through which insurers reimburse health care providers and are widely used to improve the quality and value of health care. While there is a growing movement to ut...

    Authors: Elian Rosenfeld, Sarah Potter, Jennifer Caputo, Sushmita Shoma Ghose, Nelia Nadal, Christopher M. Jones, Margaret R. Kuklinski, Andrew D. Carlo, D. Max Crowley, Lisa Clemans-Cope and Michael T. French
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:4
  18. Global demand for the treatment of cannabis use disorder has increased significantly, prompting a need to understand effective strategies for addressing concurrent cannabis and tobacco use. This study focuses ...

    Authors: Cristina Martínez, Marga Pla, Ariadna Feliu, Marta Enríquez, Judith Saura, Carmen Cabezas, Joan Colom, Josep M. Suelves, Sílvia Mondon, Pablo Barrio, Magalí Andreu, Antònia Raich, Jordi Bernabeu, Xavier Roca, Maite Narváez and Esteve Fernández
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:3
  19. Legitimate androgen use, such as testosterone replacement therapy, requires a legal prescription. Off-label use for reasons like wellness and aesthetics continues to grow. Recent regulatory changes in Australi...

    Authors: Timothy Piatkowski, Lkhagvadulam Ayurzana, Michelle King, Laetitia Hattingh and Sara McMillan
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:2
  20. Given the changes in trends of cannabis use (e.g., product types), this study examined latent classes of young adult use and associations with use-related outcomes.

    Authors: Carla J. Berg, Cassidy R. LoParco, Katelyn F. Romm, Yuxian Cui, Darcey M. McCready, Yan Wang, Y. Tony Yang, Hannah S. Szlyk, Erin Kasson, Rishika Chakraborty and Patricia A. Cavazos-Rehg
    Citation: Substance Abuse Treatment, Prevention, and Policy 2025 20:1
  21. The widely implemented prevention program in Brazil, PROERD (a translated version of the DARE-kiR program), showed no evidence of effect in preventing drug use in a recent trial. The lack of cultural adaptatio...

    Authors: Juliana Y. Valente, Bianca Franciosi, Rodrigo Garcia-Cerde, Tania Pietrobon and Zila M. Sanchez
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:48
  22. Section 1262 Consolidated Appropriations Act of 2023 eliminates the federal DATA waiver registration requirement to prescribe buprenorphine for opioid use disorder (OUD), along with patient limits, perhaps as ...

    Authors: Carolyn Carpenedo Mun, Rachel Zambrano, Eileen Tallman, Heather Schuler, Elena Bresani and Kathleen Meyers
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:47
  23. There is an increased demand for quality treatment and rehabilitation services for people who use drugs (PWUDs) in the Philippines. In response, the Philippines Government’s Department of Health (DOH) has esta...

    Authors: Shogo Kanamori, Tomohiro Shirasaka, Ma. Teresa Iñigo, Alfonso Villaroman, Rosalina Noguera-Caoile, Aya Mizusawa, Jasmin Peralta and Takayuki Harada
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:46
  24. With the broad recognition of increased U.S. opioid overdose (OOD) rates between 2020 and 2021, media, public health, and healthcare organizations have raised significant concerns over the emergence of a simul...

    Authors: S. Scott Graham, Nandini Sharma, Tristin B. Hooker, Kimberlyn Harrison and Kasey Claborn
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:45
  25. In March 2020, British Columbia, Canada, introduced prescribed safer supply involving the distribution of pharmaceutical grade alternatives to the unregulated toxic drug supply. Prior research has demonstrated...

    Authors: Karen A. Urbanoski, Thea van Roode, Marion Selfridge, Katherine C. Hogan, James Fraser, Kurt Lock, Phoenix Beck McGreevy, Charlene Burmeister, Brittany Barker, Amanda Slaunwhite, Bohdan Nosyk and Bernadette Pauly
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:44
  26. Previous research has investigated the association between attachment styles and smoking behaviors, indicating a positive association of insecure attachment styles with nicotine dependence. However, these link...

    Authors: Maria Nicoleta Turliuc, Octav-Sorin Candel and Mihaela Jitaru
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:43
  27. Widespread health service disruptions resulting from the COVID-19 pandemic coincided with a dramatic increase in overdose deaths among people who use drugs (PWUD) in Vancouver, Canada. Those with a history of ...

    Authors: Anjali Sergeant, Paxton Bach, Jingxin Lei, Kora DeBeck, M-J Milloy and Kanna Hayashi
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:42
  28. Risky behaviours, including tobacco use, are highly prevalent among adolescents worldwide. Although these behaviours are largely influenced by various sociodemographic factors, including sex, there is a paucit...

    Authors: Richard Gyan Aboagye, Aliu Mohammed, Precious Adade Duodu, Qorinah Estiningtyas Sakilah Adnani, Abdul-Aziz Seidu and Bright Opoku Ahinkorah
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:41
  29. Examining support for substance use policies, including those for harm reduction, among the general public and policy influencers is a fundamental step to map the current policy landscape and leverage policy o...

    Authors: Kimberley D. Curtin, Mathew Thomson, Elaine Hyshka, Ian Colman, T. Cameron Wild, Ana Paula Belon and Candace I.J. Nykiforuk
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:40
  30. Veterans with substance use disorder (SUD) are at high risk for cognitive problems due to neurotoxic effects of chronic drug and alcohol use coupled in many cases with histories of traumatic brain injury (TBI)...

    Authors: James M. Bjork, Jarrod Reisweber, Paul B. Perrin, Paul E. Plonski and Clara E. Dismuke-Greer
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:39
  31. The prevalence and influence of gangs on adolescents and young adults remain a concern in Western Cape, South Africa—particularly as they have one of the largest gang presence. While less attention has been fo...

    Authors: Felicia A. Browne, Tara Carney, Bronwyn Myers, Courtney Peasant Bonner and Wendee M. Wechsberg
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:38
  32. Some people with substance use disorders (SUD) can experience multiple co-occurring social problems. Digital solutions have been developed to support effective and cost-effective social welfare and healthcare ...

    Authors: Janika Kosonen, Gillian W. Shorter and Katja Kuusisto
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:36
  33. The aim of the current study was to assess the accuracy of expert predictions, which were derived using a Delphi panel foresight study between 2009 and 2011, on a variety of drug-related topics in Finland in 2...

    Authors: Tomi Lintonen, Karoliina Karjalainen, Sanna Rönkä, Elina Kotovirta and Solja Niemelä
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:35
  34. Evaluating the risk of relapse is a pivotal step in the treatment of patients with methamphetamine use disorder (MUD). The 30-item Stimulant Relapse Risk Scale (SRRS) was originally developed in Japan to meet ...

    Authors: Jing-Shu Lin, Yasukazu Ogai, Chun Lin, Hu-Ming Chang, Yi-Chia Wu, Ming-Chyi Huang and Su-Chen Fang
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:34
  35. The COTAT (Collaborative Opioid Taper After Trauma) Study was a randomized trial of an opioid taper support program using a physician assistant (PA) to provide pain and opioid treatment guidance to primary car...

    Authors: Mark D. Sullivan, Laura Katers, Jin Wang, Sam Arbabi, David Tauben and Laura-Mae Baldwin
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:33
  36. Research demonstrates gaps in medications for opioid use disorder uptake (MOUDs; methadone, buprenorphine, and naltrexone) especially among adolescents. These gaps may be partly attributable to attitudes about...

    Authors: Lauren M. O’Reilly, Katherine Schwartz, Steven A. Brown, Allyson Dir, Logan Gillenwater, Zachary Adams, Tamika Zapolski, Leslie A. Hulvershorn and Matthew Aalsma
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:32
  37. Sub-Saharan Africa is important to the future of alcohol and global health because the alcohol market there is expanding rapidly in a relatively young population. This entails a corresponding contest about whe...

    Authors: Matthew Lesch, Su Golder and Jim McCambridge
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:31
  38. Canada legalized recreational cannabis in 2018, and one of the primary objectives of the Cannabis Act was to protect youth by reducing their access to cannabis and providing public education. Canada has the hi...

    Authors: Toula Kourgiantakis, Ragave Vicknarajah, Judith Logan, Travonne Edwards, Eunjung Lee, Shelley Craig, Ashima Kaura, Charmaine C. Williams and Savannah Marshall
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:30
  39. Drug overdose deaths in the United States increased to historic levels in recent years, with provisional estimates indicating more than 111,000 deaths in the 12 months ending July 2023. In 2019, the Centers fo...

    Authors: April Wisdom, Stephanie Haddad, Madhumita Govindu, Francis Higgins, Nikki Filion, Kate Sullivan and Cherie Rooks-Peck
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:29
  40. Physical or mental health comorbidities are common among people with substance use disorders undergoing opioid agonist therapy. As both a preventive and treatment strategy, exercise offers various health benef...

    Authors: Einar Furulund, Siv-Elin Leirvåg Carlsen, Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Lars T Fadnes and Torgeir Gilje Lid
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:26
  41. There is little study of lifetime trauma exposure among individuals engaged in medication treatment for opioid use disorder (MOUD). A multisite study provided the opportunity to examine the prevalence of lifet...

    Authors: Monique N. Rodríguez, Dana D. Colgan, Sarah Leyde, Kenneth Pike, Joseph O. Merrill and Cynthia J. Price
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:25
  42. Since 1996, an urban community-based organization whose primary mission is to serve diverse94 and emerging community health needs has provided screening, testing, overdose prevention and training, referrals, a...

    Authors: Julie Gleason-Comstock, Cindy Bolden Calhoun, Barbara J. Locke, Naga Vijaya Lakshmi Divya Boorle, Kevin Cobty, Tiffany McKenney, Kaji O. Uddin, Samantha J. Bauer and Jinping Xu
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:24
  43. In Singapore, where drug use is a highly stigmatized and criminalized issue, there is limited understanding of the challenges faced by individuals, particularly sexual minority men, in their journey towards re...

    Authors: Tzy Hyi Wah, Adeline Jia Xin Ong, Kuhanesan N. C. Naidu, Syaza Hanafi, Kelvin Tan, Alaric Tan, Tricia Jia Jing Ong, Eleanor Ong, Daniel Weng Siong Ho, Mythily Subramaniam, Maha Yewtuck See and Rayner Kay Jin Tan
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:23
  44. Research has established natural recovery (NR) as an important pathway to substance use recovery. Studies investigating correlates of NR have mainly focused on demographic and substance use variables rather th...

    Authors: Florian De Meyer, Amine Zerrouk, Clara De Ruysscher and Wouter Vanderplasschen
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:22
  45. Persons with opioid use disorders (OUD) and persons with substance use disorders (SUD) who inject substances have a reduced life expectancy of up to 25 years compared with the general population. Chronic liver...

    Authors: Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Tesfaye Madebo, Håvard Midgard, Olav Dalgard, Rafael Alexander Leiva and Lars T. Fadnes
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:21
  46. Withdrawal management and opioid agonist treatment (OAT) programs help to reduce some of the harms experienced by people who use substances (PWUS). There is literature on how features of drug treatment program...

    Authors: Holly Mathias, Lois A. Jackson, Jane A. Buxton, Anik Dubé, Niki Kiepek, Fiona Martin and Paula Martin
    Citation: Substance Abuse Treatment, Prevention, and Policy 2024 19:20

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.0
    5-year Journal Impact Factor: 3.4
    Source Normalized Impact per Paper (SNIP): 1.301
    SCImago Journal Rank (SJR): 1.068

    Speed 2024
    Submission to first editorial decision (median days): 44
    Submission to acceptance (median days): 174

    Usage 2024
    Downloads: 989,331
    Altmetric mentions: 543